-
319Wire StoriesStampede Gold Comes Charging Onto Juicy Stakes Casino
What’s on offer online this week SYDNEY–(BUSINESS WIRE)–Out with the old and in with the new this week. The old being the...
-
481Wire StoriesLong-term future for New Zealand’s Tiwai Point aluminium smelter secured with new power deals
MELBOURNE, Australia–(BUSINESS WIRE)–New Zealand Aluminium Smelters (NZAS) has signed 20-year electricity arrangements that secure the future of the Tiwai Point aluminium smelter...
-
468Wire StoriesYatra Online, Inc. Announces Results for the Three Months and Year Ended March 31, 2024
GURUGRAM, India & NEW YORK–(BUSINESS WIRE)–$YTRA #AirTicketing–Yatra Online, Inc. (NASDAQ: YTRA) (the “Company”), India’s leading corporate travel services provider and one of...
-
334Wire StoriesEverybody Loves Languages Reports Financial Results for the First Quarter Ended March 31, 2024
TORONTO–(BUSINESS WIRE)–Everybody Loves Languages Corp. (“ELL”) (TSX-V: ELL; OTC: LMDCF; FSE: LIMA), www.everybodyloveslanguages.com, an edtech language learning edutainment and content development company,...
-
468Wire StoriesAEye CEO Matt Fisch to Keynote at Auto Lidar Tech Conference in Suzhou, China
Event hosted by DVN and Enmore scheduled for June 21, 2024 DUBLIN, Calif.–(BUSINESS WIRE)–AEye, Inc. (NASDAQ: LIDR), a global leader in adaptive,...
-
314Wire StoriesAsia Pacific Prefabricated Construction Industry Report 2023-2027: Rising Inflation and Subsequent Surge in Material Prices to Support Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Prefabricated Construction Industry Business and Investment Opportunities Databook – 100+ KPIs, Market Size & Forecast by End Markets,...
-
367Wire StoriesIvonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China
Unprecedented: Ivonescimab Is the First Drug to Achieve Clinically Meaningful Benefit over Pembrolizumab in Randomized Phase III Clinical Trial in NSCLC Monotherapy...
-
448Wire StoriesChina Intelligent Driving Fusion Algorithm Research Report 2024: Sparse Algorithms, Temporal Fusion and Enhanced Planning and Control Become the Trend – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Intelligent Driving Fusion Algorithm Research Report, 2024” report has been added to ResearchAndMarkets.com’s offering. Intelligent Driving Fusion Algorithm Research:...
-
408Wire StoriesMorinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut
TOKYO–(BUSINESS WIRE)–#HRB—Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, has announced a groundbreaking discovery in the fundamental research...
-
404Wire StoriesCooler Master Invites You to Experience the Future of Tech at Computex 2024
Discover Groundbreaking Innovation in Pre-Built PCs, Immersive Lifestyle Tech, and Powerful Hardware Solutions TAIPEI, Taiwan–(BUSINESS WIRE)–Cooler Master, a leading provider of PC...
